MLH1 and colorectal carcinoma: Taking into account the present report, we have identified three bona fide MLH1 epimutation carriers (two previously reported in [18] and one in the present study) among 71 (4.2%) patients with MLH1-methylated CRC and in three of 20 (15%) patients with early onset or multiple tumors (Additional file 1: Figure S1).